Infection
Symposium
The emergence of drug-resistant tuberculosis in Europe: no cure possible?
Translational
Aims : To gain insights into the mechanism of bacterial drug resistance, learn about the molecular epidemiology of M. tuberculosis and the biological mechanisms that facilitate bacterial transmission, become alert about the latest official drug resistance surveillance data, become aware of the latest treatment outcome data, learn about the latest research findings regarding optimisation of the management of M/XDR-TB, become aware of the key aspects of the consensus statement for the management of M/XDR-TB and understand the WHO strategy for TB control and elimination.
08:30
Patient's testimonial
G. Spita(Iasi (Iasi), Romania)
COI
1
241
08:42
Molecular epidemiology of M. tuberculosis drug resistance in Europe
D. van Soolingen(Nijmegen, Netherlands)
COI
2
242
09:09
Drug-resistant tuberculosis in the European Union and European economic area
M. van der Werf(Stockholm, Sweden)
COI
3
243
09:36
Management of patients with M/XDR-tuberculosis in Europe
C. Lange(Borstel, Germany)
COI
4
244
10:03
Elimination of tuberculosis at a times of emerging drug resistance
D. Falzon(Genève, Switzerland)
COI
5
245
. . .